gadolinium dtpa has been researched along with Amyloid Deposits in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gonzalez-Toledo, E; Ishaq, S; Levine, SN; Nanda, A; Wilson, JD | 1 |
Cui, W; Feng, XY; Gu, B; He, H; Li, J; Li, S; Liang, CM; Qi, Z; Zhou, G | 1 |
Aguinaldo, G; Duff, K; Elliott, JI; Li, Y; Pappolla, M; Sadowski, M; Scholtzova, H; Sigurdsson, EM; Tang, CY; Turnbull, DH; Wadghiri, YZ; Wisniewski, T | 1 |
Curran, GL; Fauq, AH; Khan, MA; McCormick, DJ; Peterson, JA; Poduslo, JF; Wengenack, TM | 1 |
4 other study(ies) available for gadolinium dtpa and Amyloid Deposits
Article | Year |
---|---|
Occurrence of extensive spherical amyloid deposits in a prolactin-secreting pituitary macroadenoma: a radiologic-pathologic correlation.
Topics: Female; Gadolinium DTPA; Galactorrhea; Humans; Hyperprolactinemia; Hypogonadism; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Gland; Pituitary Neoplasms; Plaque, Amyloid; Prolactin; Prolactinoma; Tomography, X-Ray Computed | 2013 |
Detection of Aβ plaques by a novel specific MRI probe precursor CR-BSA-(Gd-DTPA)n in APP/PS1 transgenic mice.
Topics: Albumins; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Congo Red; Contrast Media; Disease Models, Animal; Drug Combinations; Gadolinium DTPA; Immunohistochemistry; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Transgenic; Molecular Probes; Neurofibrillary Tangles; Plaque, Amyloid | 2010 |
Detection of Alzheimer's amyloid in transgenic mice using magnetic resonance microimaging.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Brain; Brain Chemistry; Contrast Media; Ferrosoferric Oxide; Gadolinium DTPA; Immunohistochemistry; Iron; Magnetic Resonance Imaging; Membrane Proteins; Mice; Mice, Transgenic; Oxides; Peptide Fragments; Plaque, Amyloid; Presenilin-1 | 2003 |
Design and chemical synthesis of a magnetic resonance contrast agent with enhanced in vitro binding, high blood-brain barrier permeability, and in vivo targeting to Alzheimer's disease amyloid plaques.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Blood-Brain Barrier; Brain; Caproates; Contrast Media; Drug Design; Gadolinium DTPA; Humans; Magnetic Resonance Spectroscopy; Membrane Proteins; Mice; Mice, Transgenic; Molecular Structure; Peptide Fragments; Plaque, Amyloid; Presenilin-1; Spectrometry, Mass, Electrospray Ionization | 2004 |